DrugPatentWatch Database Preview
« Back to Dashboard
The generic ingredient in RELENZA is zanamivir. Three suppliers are listed for this compound. Additional details are available on the zanamivir profile page.
Suppliers and Packaging for NDA: 021036
Profile for product number 001
|Approval Date:||Jul 26, 1999||TE:||RLD:||Yes|
Complete Access Available with Subscription